Eads & Heald Wealth Management’s Cognizant CTSH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.14M | Sell |
18,529
-1,175
| -6% | -$84.1K | 0.57% | 74 |
|
|
2025
Q4 | $1.64M | Buy |
19,704
+541
| +3% | +$40.5K | 0.79% | 55 |
|
|
2025
Q3 | $1.28M | Buy |
19,163
+1,019
| +6% | +$73.7K | 0.61% | 68 |
|
|
2025
Q2 | $1.42M | Buy |
18,144
+245
| +1% | +$18.8K | 0.7% | 60 |
|
|
2025
Q1 | $1.37M | Sell |
17,899
-53
| -0.3% | -$4.32K | 0.7% | 64 |
|
|
2024
Q4 | $1.38M | Buy |
17,952
+220
| +1% | +$17.2K | 0.68% | 68 |
|
|
2024
Q3 | $1.37M | Sell |
17,732
-700
| -4% | -$52.1K | 0.65% | 69 |
|
|
2024
Q2 | $1.25M | Sell |
18,432
-728
| -4% | -$49.4K | 0.61% | 74 |
|
|
2024
Q1 | $1.4M | Sell |
19,160
-1,425
| -7% | -$109K | 0.65% | 75 |
|
|
2023
Q4 | $1.55M | Sell |
20,585
-263
| -1% | -$18.2K | 0.75% | 66 |
|
|
2023
Q3 | $1.41M | Sell |
20,848
-927
| -4% | -$64K | 0.74% | 66 |
|
|
2023
Q2 | $1.42M | Sell |
21,775
-2,142
| -9% | -$133K | 0.7% | 74 |
|
|
2023
Q1 | $1.46M | Sell |
23,917
-2,743
| -10% | -$172K | 0.72% | 70 |
|
|
2022
Q4 | $1.52M | Sell |
26,660
-758
| -3% | -$44.5K | 0.78% | 60 |
|
|
2022
Q3 | $1.57M | Sell |
27,418
-865
| -3% | -$56.7K | 0.89% | 48 |
|
|
2022
Q2 | $1.91M | Sell |
28,283
-194
| -0.7% | -$14.8K | 1.03% | 42 |
|
|
2022
Q1 | $2.55M | Sell |
28,477
-305
| -1% | -$26.8K | 1.18% | 25 |
|
|
2021
Q4 | $2.55M | Sell |
28,782
-275
| -0.9% | -$22.1K | 1.11% | 34 |
|
|
2021
Q3 | $2.16M | Buy |
29,057
+80
| +0.3% | +$5.9K | 1.04% | 39 |
|
|
2021
Q2 | $2.01M | Sell |
28,977
-33
| -0.1% | -$2.46K | 0.98% | 47 |
|
|
2021
Q1 | $2.27M | Sell |
29,010
-252
| -0.9% | -$19.5K | 1.16% | 29 |
|
|
2020
Q4 | $2.4M | Sell |
29,262
-152
| -0.5% | -$11.6K | 1.29% | 21 |
|
|
2020
Q3 | $2.04M | Sell |
29,414
-3,250
| -10% | -$211K | 1.22% | 30 |
|
|
2020
Q2 | $1.86M | Buy |
32,664
+511
| +2% | +$27.5K | 1.13% | 35 |
|
|
2020
Q1 | $1.49M | Sell |
32,153
-933
| -3% | -$55.6K | 1.06% | 41 |
|
|
2019
Q4 | $2.05M | Sell |
33,086
-551
| -2% | -$34.1K | 1.09% | 40 |
|
|
2019
Q3 | $2.03M | Buy |
33,637
+100
| +0.3% | +$6.32K | 1.13% | 36 |
|
|
2019
Q2 | $2.13M | Buy |
33,537
+2,464
| +8% | +$162K | 1.2% | 29 |
|
|
2019
Q1 | $2.25M | Buy |
31,073
+313
| +1% | +$21.9K | 1.3% | 19 |
|
|
2018
Q4 | $1.95M | Sell |
30,760
-172
| -0.6% | -$12K | 1.3% | 24 |
|
|
2018
Q3 | $2.39M | Buy |
30,932
+16
| +0.1% | +$1.25K | 1.37% | 14 |
|
|
2018
Q2 | $2.44M | Buy |
30,916
+673
| +2% | +$52.9K | 1.51% | 8 |
|
|
2018
Q1 | $2.44M | Sell |
30,243
-2,511
| -8% | -$198K | 1.54% | 3 |
|
|
2017
Q4 | $2.33M | Sell |
32,754
-112
| -0.3% | -$8.19K | 1.37% | 11 |
|
|
2017
Q3 | $2.38M | Sell |
32,866
-530
| -2% | -$37.2K | 1.48% | 4 |
|
|
2017
Q2 | $2.22M | Sell |
33,396
-910
| -3% | -$57.8K | 1.42% | 10 |
|
|
2017
Q1 | $2.04M | Buy |
34,306
+895
| +3% | +$51.5K | 1.32% | 16 |
|
|
2016
Q4 | $1.87M | Buy |
33,411
+155
| +0.5% | +$8.29K | 1.28% | 17 |
|
|
2016
Q3 | $1.59M | Buy |
33,256
+1,017
| +3% | +$57.9K | 1.09% | 40 |
|
|
2016
Q2 | $1.84M | Sell |
32,239
-467
| -1% | -$28.2K | 1.27% | 24 |
|
|
2016
Q1 | $2.05M | Sell |
32,706
-945
| -3% | -$54.9K | 1.42% | 10 |
|
|
2015
Q4 | $2.02M | Sell |
33,651
-325
| -1% | -$20.9K | 1.4% | 14 |
|
|
2015
Q3 | $2.13M | Sell |
33,976
-1,583
| -4% | -$99.4K | 1.52% | 3 |
|
|
2015
Q2 | $2.17M | Sell |
35,559
-1,708
| -5% | -$107K | 1.43% | 3 |
|
|
2015
Q1 | $2.33M | Sell |
37,267
-5,500
| -13% | -$324K | 1.49% | 4 |
|
|
2014
Q4 | $2.25M | Sell |
42,767
-508
| -1% | -$25.4K | 1.43% | 6 |
|
|
2014
Q3 | $1.94M | Sell |
43,275
-1,363
| -3% | -$64.1K | 1.31% | 26 |
|
|
2014
Q2 | $2.18M | Sell |
44,638
-3,708
| -8% | -$181K | 1.45% | 9 |
|
|
2014
Q1 | $2.45M | Sell |
48,346
-1,118
| -2% | -$55.9K | 1.61% | 1 |
|
|
2013
Q4 | $2.5M | Sell |
49,464
-564
| -1% | -$25.7K | 1.66% | 3 |
|
|
2013
Q3 | $2.05M | Sell |
50,028
-3,144
| -6% | -$117K | 1.47% | 11 |
|
|
2013
Q2 | $1.67M | Buy |
+53,172
| New | +$1.77M | 1.18% | 42 |
|
Other funds holding CTSH
VCM
VPM
Eads & Heald Wealth Management's CTSH Position: Q1 2026 in Review
Eads & Heald Wealth Management reduced its Cognizant (CTSH) stake by 6% in Q1 2026, selling an estimated $84.1K and leaving 18,529 shares worth $1.14M. The position accounts for 0.57% of the portfolio, ranked #74.
Eads & Heald Wealth Management first reported a position in CTSH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.55M in Q1 2022. 985 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.
- Eads & Heald Wealth Management held 18,529 shares of Cognizant worth $1.14M as of Q1 2026.
- Eads & Heald Wealth Management sold 1,175 Cognizant shares in Q1 2026, an estimated $84.1K.
- Cognizant made up 0.57% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #74 holding.
- Eads & Heald Wealth Management first reported a position in Cognizant in Q2 2013 and has held it in 52 quarters since.
- Eads & Heald Wealth Management's Cognizant position peaked at $2.55M in Q1 2022.
- 985 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.
Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.